The effect of oral vitamin E supplementation on the oxido-reductive status of red blood cells in normal mice and those subject to oxidative stress by chronic administration of the anti-tumour drug Adriamycin was investigated. Mice were randomly separated into three groups of 20 animals each and maintained on diets identical in all respects except for vitamin E content. Group 1 received a low vitamin E diet that provided 10 mg vitamin E/kg body weight/day, group 2 received a normal mice chow diet (45 mg vitamin E/kg body weight/day) while group 3 received a high vitamin E diet (200 mg vitamin E/kg body weight/day).
SUMMARY. The effect of oral vitamin E supplementation on the oxido-reductive status of red blood cells in normal mice and those subject to oxidative stress by chronic administration of the anti-tumour drug Adriamycin was investigated. Mice were randomly separated into three groups of 20 animals each and maintained on diets identical in all respects except for vitamin E content. Group 1 received a low vitamin E diet that provided 10 mg vitamin E/kg body weight/day, group 2 received a normal mice chow diet (45 mg vitamin E/kg body weight/day) while group 3 received a high vitamin E diet (200 mg vitamin E/kg body weight/day).
In comparison with the normal mice in group 1, their counterparts in groups 2 and 3 exhibited significantly higher (P<O·OOI) activities of superoxide dismutase (SOD) in red blood cells (79,4% higher in group 2 and 114·2% higher in group 3, respectively) and produced lower concentrations of malondial dehyde (MDA) (22,9% less in group 2 and 51·2% less in group 3, respectively), with little difference in the glutathione peroxidase (GPX) activity. In Adriamycin-treated animals on the low vitamin E diet (group 1) the red blood cell SOD activity and MDA production were 46·2% and 200·7% higher (P<O·OOI), respectively, and the GPX activity was 39·1% lower than in the red blood cells of untreated (normal) animals in the same group. The Adriamycin-induced changes were significantly less in animals receiving higher doses of vitamin E (groups 2 and 3). Thus, in the group maintained on the high vitamin E diet (group 3), Adriamycin administration resulted in only a 38·9% increase in the MDA production above that generated by red blood cells of normal mice in the same group, with no significant change in the SOD or GPX activities. Thus, in normal conditions as well as in conditions of oxidative stress, high doses of vitamin E appear to be able to protect the oxido-reductive status of red blood cells by modulating the extent of lipid peroxidation as well as the activities of antioxidant enzymes.
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Oxidative stress is believed to playa pivotal role in the pathogenesis of many different types of tissue injury.l-' In a recent study conducted with the blood of human cataract patients, Chandrasena et al. 3 have also concluded that estimations of Correspondence: Prof. M I Thabrew. E-mail: mrthab@sri.lanka.net 216 the oxido-reductive status of red blood cells may be useful for predicting patients who are at risk of developing senile cataracts (i.e., non-diabetic, nuclear cataracts). This study demonstrated that in non-diabetic patients who developed cataracts there was a significantly greater reduction in the reduced glutathione (GSH) concentration in red blood cells than in diabetic patients with cataracts. It is generally accepted that vitamin E can protect membranes against oxidative damage by acting both as a free radical scavenger and as a membrane stabilizer.l-' Investigations conducted both in rabbits" and humans-have demonstrated that the GSH content in red blood cells can be enhanced by oral administration of high doses of vitamin E; the vitamin E is believed to spare the GSH that would otherwise have been utilized for protection of cells against lipid peroxidation mediated by free radicals. The antioxidant activity of red blood cells depends not only on its content of GSH but also on the various antioxidant enzymes (e.g., catalase, glutathione peroxidase, superoxide dismutase) they contain, It was therefore of interest to investigate whether the protective effect of oral vitamin E supplementation on the oxido-reductive status of red blood cells involved, in addition to the sparing of GSH, alterations in the activities of antioxidant enzymes contained in these cells.
In the present investigation, the effects of oral supplementation with vitamin E on the activities of red blood cell glutathione peroxidase (GPX) and superoxide dismutase (SOD), and on lipid peroxidation, were investigated in normal mice as well as those subject to oxidative stress. Oxidative stress was induced in the animals by the administration of a chronic dose of the antitumour drug Adriamycin (doxorubicin hydrochloride). It is well documented that the administration of Adriamycin for anti-tumour purposes often results in cardiomyopathy mediated through increased oxidative stress due to the generation of free radicals.P-' Apart from demonstrating whether vitamin E supplementation could influence the activities of antioxidant enzymes in red blood cells, this study would also indicate whether estimations of changes in red blood cell antioxidant status could be useful for monitoring in a less invasive manner the beneficial effects of vitamin E supplementation for protection of other tissues against oxidative stress induced by free radical generating drugs such as Adriamycin.'
MATERIALS AND METHODS

Chemicals
Commercial reagent kits for the estimation of GPX (Cat, No. RS 506) and SOD (Cat. No. SD 125) activities were purchased from Randox Laboratories Ltd, Crumin, Co. Antrim, UK. Adriamycin (doxorubicin hydrochloride) was purchased from Farmitalia Carlo Erba (Cat.
No. L 6010005), Erbamont group, Milan, Italy. All other chemicals were purchased from Sigma Chemical Co. Ltd (Poole, Dorset, UK),
Animals
Litter-mate male mice of body weight 30 ±5 g [maintained on a mice chow diet prepared by the Medical Research Institute of Sri Lanka according to a formulation recommended by the World Health Organization (WHO)9] were used in the study. The animals had free access to drinking water at all times.
Assessment of the effects of oral vitamin E administration on red blood cell antioxidant enzymes and lipid peroxidation Mice (n = 60) were divided into three groups (20 animals in each group) on the basis of their vitamin E intake. Thus, animals in all three groups were fed for 2 weeks on mice chow diets identical in all respects with the exception of their vitamin E contents. The animals in group 1 received a low vitamin E diet that provided the mice with only 10mg vitamin E/kg body weight/ day. Group 2 received the normal mice chow diet that provided 45 mg vitamin E/kg body weight/day, while animals in group 3 received a diet that provided 200 mg vitamin E/kg body weight/day (high vitamin E diet). All animals had free access to drinking water during the experimental period.
At the end of the 2-week period diets with different concentrations of vitamin E, oxidative stress was induced in half the animals in each group by administering Adriamycin intraperitoneally in 3 equal injections (each containing 5 mg Adriamycin/kg body weight) for 3 days (cumulative dose was 15mg Adriamycin/kg body weight). Animals in the remaining half of each group were administered each day a volume of intraperitoneal saline equivalent to the dose of Adriamycin administered to the other mice.
On the fourth day after the last Adriamycin (or saline) dose, blood was collected from each mouse by cardiac puncture, for assessment of the activities of red blood cell GPX and SOD, and the extent of lipid peroxidation as estimated by the concentration of malondialdehyde in plasma,
Bioassays
Glutathione peroxidase assay GPX activity was measured by the method of Paglia and Valentine'? using commercially available reagent kits from Randox Laboratories Ltd. Enzyme activity was expressed as U/g haemoglobin.
Superoxide dismutase assay
Erythrocyte SOD activity was assayed according to the method described in the assay kit purchased from Randox Laboratories Ltd. In this method, xanthine and xanthine oxidase are used to generate SOD radicals which react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyl tetrazolium chloride to form a red formazan dye. SOD activity is then measured by the degree of inhibition of this reaction. Enzyme activity was expressed as U/g haemoglobin.
Malondialdehyde (MDA) assay
Plasma MDA concentration was estimated by reacting it with thiobarbituric acid in the presence of butylated hydroxy toluene, and measuring the absorbance at 535 nm of the pink coloured complex formed against a reagent blank (as described by Aust!'),
Estimation of blood haemoglobin concentration
The haemoglobin concentration was estimated by the cyanomethaemoglobin photometric method recommended by the WHO. 12 
Statistical analysis
Results are expressed as means (SD). Statistical analysis was carried out according to Student's t-test. Significant differences between groups were determined by means of the Mann-Whitney U-test.
RESULTS
The effects of increasing the dosage of orally administered vitamin E on the red blood cell GPX and SOD activities and on lipid peroxidation as assessed by the plasma malondialdehyde concentration, in normal mice and those subject to oxidative stress by administration of chronic doses of Adriamycin, are summarized in Table 1 .
In normal mice (untreated with Adriamycin), vitamin E produced a significant, dose-dependent increase in SOD activity along with a small but significant decrease in the generation of MDA, with little apparent effect on the GPX activity. Thus, in normal mice in groups 2 and 3, the SOD activities were 79·4 (SD 14,9) % and 114·2 (SD 22,1) % higher, respectively, and the MDA production was 22·9 (SD4'1) % and 51·2 (SD 3,5) % less than the SOD activity or MDA production in corresponding animals belonging to group 1.
As previously reported for the heart tissue of rats," chronic administration of Adriamycin to Ann C/in Biochem 1999: 36 mice also resulted in a significant elevation of red blood cell SOD activity and MDA production along with a decrease in the GPX activity, indicating that the drug can affect the oxidative status of both the heart tissue and red blood cells in a similar manner. The effects of Adriamycin on mouse red blood cell antioxidant status were highest in the group of animals maintained on a low vitamin E diet (group I). The toxic effects of Adriamycin were significantly less in the groups administered diets containing higher vitamin E concentrations (groups 2 and 3).
Thus, in Adriamycin-treated animals of group 1, the red blood cell SOD activity and MDA production were 46·2 (SDIO'I)% and 200·7 (SD 109) % higher, respectively, and the GPX activity 39·1 (SD 4, 9) % lower than in untreated (normal) animals in the same group. In group 3 animals Adriamycin administration resulted in only a 38·9 (SD4'8) % increase in the MDA production above that generated by red blood cells of normal mice in the same group, with no significant changes in the SOD or GPX activities.
DISCUSSION
The dose-dependent effects of vitamin E on the activities of red blood cell antioxidant enzymes and lipid peroxidation seen in the present investigation are very similar to those previously observed by Siveski-Iliskovic et al. 6 in rats on administration of probucol, another compound with antioxidant activity. Probucol (at a dose of 60 mg/kg body weight) alone, when administered to rats for a 2-week period, was found to cause a significant increase (by approximately 33%) in rat heart SOD activity, with little change in GPX activity; the reason for the drug-induced increase in SOD activity was not understood. The reason for the vitamin Einduced increase in red blood cell SOD activity observed in the present investigation is also not clear. The inhibition of lipid peroxidation by vitamin E observed in the present investigation is most probably due to its free radical scavenging property, as has been demonstrated in many other tissues by previous investigators.P 16 According to the results of an investigation in humans, conducted by Costagliola and Menzione.v'" high doses of vitamin E can improve the oxido-reductive status of red blood cells by enhancing the GSH concentration in these cells; the vitamin E is believed to spare GSH that would otherwise have been utilized for protection of the cells against free-radicalmediated injury through lipid peroxidation. The effect of vitamin E on red blood cell SOD activity and MDA production observed in the present investigation (see Table I ) demonstrates that an improvement of the 'endogenous antioxidant reserve' of red blood cells can occur not only because of a vitamin E-mediated decrease in lipid peroxidation but also due to an improvement in the activities of some of its antioxidant enzymes.
A study by Myers et al. s has demonstrated that pre-treatment of mice with vitamin E (a single dose of 85 IV, administered intraperitoneally) can provide protection against Adriamycin-induced acute cardiac cell damage, as assessed by histological examination of heart tissue and estimation of lipid peroxidation in this tissue. In the present investigation it was also observed that a significant reduction in the adverse effects of Adriamycin on the antioxidant status of red blood cells could be achieved by increasing the vitamin E content of diets administered to mice. Protection against the Adriamycin-induced changes is most probably related to the ability of vitamin E to enhance the endogenous antioxidant reserve in red blood cells, as observed in mice not treated with the drug. However, at this stage it is not possible to be certain whether vitamin E also has other indirect effects, such as the ability to assist in the hepatic detoxification of Adriamycin, that can contribute to improving the antioxidant status of red blood cells in the Adriamycin-treated animals.
From the overall results obtained it is apparent that the oxido-reductive status of red blood cells can be significantly improved by dietary supplementation with vitamin E. Vitamin E supplementation, apart from improving the endogenous antioxidant reserve of red blood cells, can also protect these organelles against oxidative damage mediated by the free-radicalgenerating drug Adriamycin. Whether this effect is due only to a direct effect of the vitamin E on peroxidative changes mediated by Adriamycin or is due to a combination of antiperoxidative effect and a decrease in the active concentration of Adriamycin in the circulation (due to a possible vitamin E-mediated enhancement of hepatic detoxification of the drug) needs further investigation. The present investigation also reveals that Adriamycin-induced alterations in red blood cell antioxidant enzyme activities and lipid peroxidation are qualitatively very similar to those reported in heart tissue during the administration of this drug as an anti-tumour drug." The administration of antioxidant compounds such as vitamin E S and probucol" are believed to be beneficial in preventing the toxic side effects of Adriamycin. In the present study vitamin E was able to protect red blood cells against Adriamycin-induced oxidative injury in a manner similar to the protective effects of the antioxidant compound probucol (i.e., against toxicity induced in heart tissue by Adriamycin).
Estimations of red blood cell oxido-reductive status may therefore prove to be a convenient method of monitoring the therapeutic benefits of antioxidant administration for protection against Adriamycin-induced cardiotoxicity.
